Format

Send to

Choose Destination
Lancet Oncol. 2016 Aug;17(8):1032-1033. doi: 10.1016/S1470-2045(16)30149-8. Epub 2016 Jul 9.

A prognostically relevant miRNA signature for epithelial ovarian cancer.

Author information

1
Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: dcramer@partners.org.
2
Harvard Medical School, Boston, MA, USA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
PMID:
27402146
DOI:
10.1016/S1470-2045(16)30149-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center